2.1. Subjects
FamilyGL: N/A
FamilyPresentingHPOs: HP:0012237 (Urocanic aciduria)
HPOsFreeText: N/A
FamilyNotHPOs: HP:0001507, HP:0100543, HP:0010904 (Growth abnormality, Cognitive impairment, Abnormal circulating histidine concentration)
NotHPOsFreeText: N/A
FamilyGenotypingMethod: Genomic DNA was obtained via peripheral blood from the siblings and both parents. PCR and direct sequencing in both forward and reverse directions was used to amplify and sequence the 21 coding exons of UROC1.
FamilyPreviousTesting: Plasma samples from both subjects demonstrated significant elevations in cis-urocanate, trans-urocanate and imidazole propionate; Z-scores for compounds in alternative histidine degradation pathways were found to be within normal limits, including 1-methylhisitidine, imidazole lactate, and 1-methylhistamine; Table 1 shows detailed metabolite levels; Family history was negative for metabolic disorders or any other familial diseases
FamilyAddInfo: Family appears to be asymptomatic, Siblings are confirmed compound heterozygous via parental sequencing (father het for Variant 2, mother het for Variant 1)
Variant1: NM_144639.3:c.356C>G (p.Pro119Arg)
CAID: CA2591587, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA2591587
gnomAD: 0.0001596, https://gnomad.broadinstitute.org/variant/3-126227314-G-C
Variant2: NM_144639.3:c.907G>C (p.Ala303Pro)
CAID: CA2591263, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA2591263
gnomAD: 0.00009300, https://gnomad.broadinstitute.org/variant/3-126220119-C-G
Affected: 2
Unaffected: 3
AddSegregationInfo: Not enough affected